{
    "clinical_study": {
        "@rank": "84014", 
        "arm_group": [
            {
                "arm_group_label": "Propranolol", 
                "arm_group_type": "Active Comparator", 
                "description": "Propranolol by mouth given daily throughout hospitalization for up to 12 months"
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo by mouth given daily throughout hospitalization for up to 12 months"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the safety and efficacy of administration of propranolol for reducing heart\n      rate and blood pressure in burn injury."
        }, 
        "brief_title": "Propranolol in Severely Burned Children", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Burn", 
        "detailed_description": {
            "textblock": "Other purposes of this study are to study the effect on muscle function, the infectious\n      process, sepsis, systemic inflammation and long-term scarring.  Quality of life will also be\n      looked at over time."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Burns covering >30% of the total body surface are\n\n          -  Age of 0.5 to 18 years\n\n          -  Patient arrival to the burn center within 96 hours (4 days) of burn injury\n\n          -  Require > 1 surgical procedure\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Known history of AIDS, ARC, or HIV\n\n          -  History of cancer within 5 years\n\n          -  Existence of pre-morbid conditions\n\n          -  Asthma\n\n          -  Congestive heart failure (measured ejection fraction < 20%)\n\n          -  Medical condition requiring glucocorticoid treatment\n\n          -  Burn injury due to chemical burns\n\n          -  Burn injury due to deep electrical injury (decision of hospital PI)\n\n          -  Presence of anoxic brain injury that is not expected to result in complete\n             recovery\n\n          -  Decision not to treat due to burn injury severity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957449", 
            "org_study_id": "13-103"
        }, 
        "intervention": [
            {
                "arm_group_label": "Propranolol", 
                "description": "Propranolol by mouth given daily throughout hospitalization for up to 12 months", 
                "intervention_name": "Propranolol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Metroprolol", 
                    "inderal"
                ]
            }, 
            {
                "arm_group_label": "Sugar Pill", 
                "description": "Placebo by mouth given daily throughout hospitalization for up to 12 months.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Control"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Propranolol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 12, 2013", 
        "location": [
            {
                "contact": {
                    "email": "DGHalgh@shrinenet.org", 
                    "last_name": "David Greenhalgh, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "Shriners Hospitals for Children"
                }, 
                "investigator": {
                    "last_name": "David Greenhalgh, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "rsheridan@partners.org", 
                    "last_name": "Robert Sheridan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Shriners Hospitals for Children"
                }, 
                "investigator": {
                    "last_name": "Robert Sheridan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "rkagan@shrinenet.org", 
                    "last_name": "Richard Kagan, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229"
                    }, 
                    "name": "Shriners Hospitals for Children"
                }, 
                "investigator": {
                    "last_name": "Richard Kagan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ca2reed@utmb.edu", 
                    "last_name": "Cathy Reed, BSN", 
                    "phone": "409-770-6987"
                }, 
                "contact_backup": {
                    "email": "dbenjami@utmb.edu", 
                    "last_name": "Deb Benjamin, MSN", 
                    "phone": "409-770-6731"
                }, 
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77551"
                    }, 
                    "name": "Shriners Hospitals for Children"
                }, 
                "investigator": {
                    "last_name": "David N Herndon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Safety and Efficacy of Propranolol in Severely Burned Children", 
        "overall_contact": {
            "email": "ca2reed@utmb.edu", 
            "last_name": "Catherine Reed, RN", 
            "phone": "409-770-6987"
        }, 
        "overall_contact_backup": {
            "email": "dbenjami@utmb.edu", 
            "last_name": "Deb Benjamin, RN", 
            "phone": "409-770-6731"
        }, 
        "overall_official": {
            "affiliation": "University of Texas", 
            "last_name": "David N Herndon, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Multiply the subjects resting heart rate and systolic blood pressure measurements and average every 24 hours while hospitalized (an average of 4 weeks)", 
            "measure": "Resting heart rate multiplied by the systolic blood pressure measurement= rate pressure product", 
            "safety_issue": "No", 
            "time_frame": "Measured during acute hospital stay, an average of 4 weeks."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957449"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Number of deaths will be compared between placebo group and propranolol treatment groups.", 
            "measure": "Number of deaths", 
            "safety_issue": "Yes", 
            "time_frame": "time of randomization up to one year"
        }, 
        "source": "The University of Texas, Galveston", 
        "sponsors": {
            "collaborator": {
                "agency": "Shriners Hospitals for Children", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}